Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
Previous guidelines for the treatment of people with type 2 diabetes mellitus (T2D) have relied heavily upon rigid algorithms for the sequential addition of pharmacotherapies to achieve target glycemic control. More recent guidelines advocate a personalized approach for diabetes treatment, to improve patient satisfaction, quality of life, medication adherence and overall health outcomes. Clinicians should work with patients to develop personalized goals for their treatment, including targeted glycemic control, weight management, prevention and treatment of associated comorbidities and avoidance of complications such as hypoglycemia. Factors that affect the intensity of treatment and choice of pharmacotherapy should include medical and patient influences. Medical considerations include the diabetes phenotype, biomarkers including genetic tests, and the presence of comorbidities such as cardiovascular, renal, or hepatic disease. Patient factors include their treatment preference, age and life expectancy, diabetes duration, hypoglycemia fear and unawareness, psychological and social circumstances. The use of a personalized approach in the management of people with T2D can reduce the cost and failure associated with the algorithmic "one-size-fits-all" approach, to anticipate disease progression, improve the response to diabetes pharmacotherapy and reduce the incidence of diabetes-associated complications. Ultimately, the use of personalized medicine in people with T2D should improve medication adherence, patient satisfaction and quality of life to reduce diabetes distress and improve physical health outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“Their use in people with T2D can support an additional weight loss of 2 to 4kg.76 Metformin use is considered at least weight neutral though may be associated with a modest weight loss, as observed in the Diabetes Prevention Program.81 The use of DPP-IV inhibitors in people with T2D is considered weight neutral.82 The…”
BackgroundEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900 · cited 1×
“9kg in people with T2D.(51) In a dedicated weight loss trial of overweight and obese patients (with or without T2D), semaglutide 2.”
BackgroundDapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
Cited by
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Piragine, E., Petri, D., Martelli, A., Calderone, V., & Lucenteforte, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051981 · Cited by 149
Genetics of Type 2 Diabetes: Past, Present, and Future
Laakso, M., & Silva, L. F. (2022) · Nutrients · doi:10.3390/nu14153201 · Cited by 108
Human Digital Twin for Personalized Elderly Type 2 Diabetes Management
Thamotharan, P., Srinivasan, S., Kesavadev, J., Krishnan, G., Mohan, V., Seshadhri, S., Bekiroglu, K., & Toffanin, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062094 · Cited by 106
Varney, M. J., & Benovic, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001015 · Cited by 90
Pereira, L., & Valado, A. (2023) · Life · doi:10.3390/life13091831 · Cited by 77
Bercea, M., & Lupu, A. (2024) · Gels · doi:10.3390/gels10040260 · Cited by 65
Evolving paradigms in nutrition therapy for Diabetes: From carbohydrate counting to precision diets
Alum, E. U., Obasi, D. C., Abba, J. N., Aniokete, U. C., Okoroh, P. N., & Akwari, A. A. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100622 · Cited by 51
Vaibhav, V., Nishad, S., Dongare, D. B., Tripathi, A. C. P., Tripathi, T., & Tripathi, P. (2024) · Health Sciences Review · doi:10.1016/j.hsr.2024.100201 · Cited by 40
Abdalla, M. M. I., & Mohanraj, J. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i5.101306 · Cited by 32
Tahir, F., & Farhan, M. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1316111 · Cited by 29
Jones, C. H., Madhavan, S., Natarajan, K., Corbo, M., True, J. M., & Dolsten, M. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104112 · Cited by 26
Ying, L. P., Yin, O. X., Quan, O. W., Jain, N., Mayuren, J., Pandey, M., Gorain, B., & Candasamy, M. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01349-x · Cited by 23
Oxidative Stress and Diabetes Mellitus: Unravelling the Intricate Connection: A Comprehensive Review
Rais, N., Ved, A., Ahmad, R., & Parveen, A. (2024) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2024/v36i17493 · Cited by 20
Dsouza, S. M., Venne, J., Shetty, S., & Brand, H. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01414-9 · Cited by 20
Dholariya, S. J., Dutta, S., Singh, R., Parchwani, D. N., Sonagra, A. D., & Kaliya, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2269854 · Cited by 18
Sen, A., Mohanraj, P. S., Laxmi, V., Ashique, S., Vasudevan, R., Aldahish, A. A., Velu, A., Das, A., Ehsan, I., Islam, A., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101305 · Cited by 17
Chen, J., Li, Y., Chen, J., Wang, R., Lu, M., & Yu, C. B. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05281-1 · Cited by 15
Uddin, S., Machado, M. S., Alshahrouri, B., Echeverri, J. I., Rico, M. C., Rao, A. D., Ruchalski, C., & Barrero, C. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113822 · Cited by 15
Platelet-Rich Plasma for Wound Healing in Diabetic Patients
Zanzov, E. I., Anastasova, V., Ivanova, K., & Kiskinov, P. (2025) · Medicina · doi:10.3390/medicina61091535 · Cited by 15
Ebadi, A. G., & Selamoğlu, Z. (2025) · Wah Academia Journal of Health and Nutrition · doi:10.63954/sns00e14 · Cited by 14
The mechanism of action of Spirulina as antidiabetic: a narrative review
El-Sakhawy, M. A.-M., Iqbal, M. Z., Gabr, G. A., Alqasem, A. A., Ateya, A. A. E.-S., Ahmed, F. A., El-Hashash, S. A., Ibrahim, H., & El-Ghiet, U. M. A. (2023) · Italian Journal of Medicine · doi:10.4081/itjm.2023.1639 · Cited by 14
Transform diabetes care with precision medicine
Kannan, S., Chellappan, D. K., Kow, C. S., Ramachandram, D. S., Pandey, M., Mayuren, J., Dua, K., & Candasamy, M. (2023) · Health Science Reports · doi:10.1002/hsr2.1642 · Cited by 14
Shang, F., & Yu, L. (2025) · Journal of Advanced Computing Systems · Cited by 12
Ng, C. Y. J., Zhong, L. L. D., Ng, H. S., Goh, K. S., & Zhao, Y. X. (2024) · Nutrients · doi:10.3390/nu16223935 · Cited by 12
Henao-Carrillo, D. C., Sierra-Matamoros, F. A., Carrillo Algarra, A. J., García-Lugo, J. P., & Hernández-Zambrano, S. M. (2023) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102917 · Cited by 11
Healey, E., Morato, C. W., Murillo, J. E., & Kohane, I. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16432 · Cited by 11
Etiologies underlying subtypes of long-standing type 2 diabetes
Bayoumi, R., Farooqi, M. H., Alawadi, F., Hassanein, M. M., Osama, A., Mukhopadhyay, D., Abdul, F., Sulaiman, F., Dsouza, S., Mulla, F., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304036 · Cited by 11
Hasaini, A., Muhlisoh, M., & Sukmawaty, M. N. (2023) · Indonesian Journal of Global Health Research · doi:10.37287/ijghr.v5i2.1870 · Cited by 11
Dai, X., Yu, K., Chang, Y., & Hou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1466875 · Cited by 10
Luca, S. A., Bungau, R. M., Lazăr, S., Potre, O., & Timar, B. (2024) · Medicina · doi:10.3390/medicina60020334 · Cited by 10
Giorgino, F., Bonfanti, R., Castaldo, F., Irace, C., Laurenzi, A., Maffeis, C., Pappagallo, G. L., Pitocco, D., Rabbone, I., Zarra, E., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251316577 · Cited by 10
Chandra, G., Lavikainen, P., Siirtola, P., Tamminen, S., Ihalapathirana, A., Laatikainen, T. K., Martikainen, J. A., & Röning, J. (2025) · Clinical Epidemiology · doi:10.2147/clep.s505966 · Cited by 10
Kiconco, R., Lumumba, S. A., Bagenda, C. N., Atwine, R., Ndarubweine, J., & Rugera, S. P. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241232280 · Cited by 10
Methods in dynamic treatment regimens using observational healthcare data: A systematic review
Liang, D., Paul, A. K., Weir, D. L., Deneer, V. H. M., Greiner, R., Siebes, A. P. J. M., & Gardarsdóttir, H. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.108658 · Cited by 9
Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development
Vo, D.-K., & Trinh, K. T. L. (2025) · Micromachines · doi:10.3390/mi16030243 · Cited by 9
Kourtidou, C., Rafailidis, V. D., Varouktsi, G., Kanakis, E., Liakopoulos, V., Vyzantiadis, T., Stangou, M. J., Marinaki, S., & Τζιόμαλος, Κ. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071139 · Cited by 8
Shazman, S. (2023) · Nutrients · doi:10.3390/nu15183926 · Cited by 8
Arabshahi, V., Amiri, R., Ghalishourani, S. S., Hasaniani, N., Nozarian, S., Tavasolian, R., Khiabani, A., & Rahimlou, M. (2023) · BMC Nutrition · doi:10.1186/s40795-023-00803-z · Cited by 8
Adam, C. A., Popiołek-Kalisz, J., Akıncı, B., Manzi, G., Ullah, I., Beneki, E., Mitu, F., Baťalík, L., Ostojic, M., & Perone, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217791 · Cited by 7
Multi-agent norm perception and induction in distributed healthcare
Li, C., Petruchik, O., Grishanina, E., & Kovalchuk, S. V. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104835 · Cited by 7
Rongala, G., Rongala, D. S., & Rongala, A. N. (2025) · Journal of Pharmaceutical and BioTech Industry · doi:10.3390/jpbi2040019 · Cited by 7
The Link Between Immune Aging and Type 2 Diabetes: A Review of Mechanisms and Implications
Chakrabarti, S. K., & Chattopadhyay, D. (2025) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2025.00018 · Cited by 6
Consolazio, D., & Russo, A. G. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118435 · Cited by 6
Bhagya, G., Namini, M. T., Girish, B. S., & Srinivasan, R. (2025) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.274 · Cited by 6
Kalra, S., Bhattacharya, S., Dhingra, A., Das, S., Kapoor, N., Shaikh, S. S., Kolapkar, V., Kumar, R. V. L., Patel, K., & Kotwal, R. (2024) · Cureus · doi:10.7759/cureus.61766 · Cited by 6
Lee, S.-Y., Hayes, L. W., Ozaydin, B., Howard, S., Garretson, A. M., Bradley, H. M., Land, A. M., DeLaney, E. W., Pritchett, A. O., Furr, A. L., et al. (2024) · JMIR Research Protocols · doi:10.2196/56049 · Cited by 5
Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review
Belhadj, M., Malek, R., Baghous, H., Boukheloua, M., Arbouche, Z., Nouri, N., Amani, M. E. A., Sersoub, F., & Haireche, M. A. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1495849 · Cited by 5
Kalita, D., Sharma, H., & Mirza, K. B. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.128833 · Cited by 5
Wang, M., Sushil, M., Williams, C. Y. K., Miao, B. Y., Kim, S., Masharani, U. B., Ku, G., Hsiao, V. C., Shah, A., Koliwad, S. K., et al. (2025) · Clinical Diabetes · doi:10.2337/cd25-0015 · Cited by 5
Mahmoud, F., Mueller, T., Mullen, A. B., Sainsbury, C. A. R., Rushworth, G. F., & Kurdi, A. B. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15584 · Cited by 5
Yousuf, A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01684-8 · Cited by 5
Kimura, M., Toyoda, M., Saito, N., Takahashi, M., Isozumi, K., Kato, E., Kawanami, D., & Fukagawa, M. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s363762 · Cited by 5
Bromocriptine and Colesevelam Hydrochloride: Novel Therapies for Type II Diabetes Mellitus
Soileau, L. G., Nguyen, A., Senthil, A., Boullion, J. A., Talbot, N. C., Ahmadzadeh, S., Shekoohi, S., Kaye, A. D., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.50138 · Cited by 5
Szer, J., Panse, J., Kulasekararaj, A. G., Oliver, M., Fattizzo, B., Nishimura, J., Horneff, R., Szamosi, J., & de Latour, R. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168591 · Cited by 5
Aberra, Y. T., Ma, L., Björkegren, J., & Civelek, M. (2023) · eLife · doi:10.7554/elife.79834 · Cited by 5
Marchianò, V., Pellegrini, C., Tricase, A., Macchia, E., Brattelli, A., Gentile, L., Hanieh, P. N., Fiaschini, N., Rinaldi, A., Torsi, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202516912 · Cited by 4
Machine learning classification approaches for prediction of effective diabetes drugs
Abdelbaky, I., Ahmed, M., & Taha, M. (2025) · Egyptian Informatics Journal · doi:10.1016/j.eij.2025.100786 · Cited by 4
Diabetes mellitus in privately insured autistic adults in the United States
Gilmore, D., & Hand, B. N. (2023) · Autism · doi:10.1177/13623613231206421 · Cited by 4
Kim, N. H., Moon, J. S., Ha, K. H., Kim, J., Kwon, K.-E., Kim, S. G., & Kim, D. J. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112405 · Cited by 4
Information needs for GPs on type 2 diabetes in Western countries: a systematic review
Andersen, T. H., Marcussen, T. M., & Nørgaard, O. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0531 · Cited by 4
Javed, A., Tariq, M., Hussain, G., Ali, S., Fatima, A., Batool, A., Khalid, D., Noor, Z., & Rasul, S. (2024) · Developmental medico-life-sciences · doi:10.69750/dmls.01.06.058 · Cited by 4
Tichler, A., Hertroijs, D. F. L., Ruwaard, D., Brouwers, M. C. G. J., Hiligsmann, M., de Jong, J. D., & Elissen, A. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s397647 · Cited by 4
Simayi, D., & Guan, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s361843 · Cited by 4
Zhao, S., Li, H., Jing, X., Zhang, X., Li, R., Li, Y., Liu, C., Chen, J., Li, G., Zheng, W., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1210667 · Cited by 4
Antidiabetic Herbs and Polyherbal Strategies: A Dual Approach to Diabetes Control
Chauhan, A., Janmeda, P., Singh, H., Gaur, R., NARGIS, K. M., & Kanta, C. (2024) · Environment Conservation Journal · doi:10.36953/ecj.28302870 · Cited by 3
Golembiewski, E. H., Ning, X., Mickelson, M. M., Gockerman, J. P., Tesulov, M., Labatte, B., & McCoy, R. G. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09509-3 · Cited by 3
Zin, C. A. J. C. M., Ishak, W. R. W., Khan, N. A. K., & Mohamed, W. M. I. W. (2024) · PubMed Central · Cited by 3
Wyszogrodzka, G., Shuklinova, O., Lisowski, B., Wiśniowska, B., & Polak, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103731 · Cited by 3
Kirwan, M., Chiu, C. L., Henson, C., Laing, T., Fermanis, J., Scott, L., Janszen, J., & Gwynne, K. G. (2024) · Diabetology · doi:10.3390/diabetology5070049 · Cited by 2
Majd, Z., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., Fatima, B., & Abughosh, S. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109080 · Cited by 2
Ostrominski, J. W., Aroda, V. R., Braae, U. C., Kruse, C., Mandavya, K., & Buse, J. B. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01751-6 · Cited by 2
A New Era in Diabetes Management: Generative Artificial Intelligence
Göktaş, M., & Bilgehan, T. (2024) · DergiPark · Cited by 2
Xin, M., Yao, Y., Huang, P. C., & Li, Q. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1735295 · Cited by 2
Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–2024
Lux, T. S., Lee, D., Phillips, J. M., Facelli, J. C., Malone, D. C., Wahl, M., Reddy, D., Sakaguchi, F. H., Gouripeddi, R., Millar, A. S., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71013 · Cited by 2
Jin, S., Tan, L., Zhao, W., Dai, W., Wu, L., & Zhou, Q. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.70444 · Cited by 2
Shokr, E. A., EL-Marakby, R. M., AL-Olimat, K. A., Alqadi, R. A., Alsirhani, H. S., Abdelaziz, S., Hassan, A., & Afify, A. (2025) · Retos · doi:10.47197/retos.v68.116122 · Cited by 2
Complex metabolic–endocrine syndromes: associations with cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00010-3 · Cited by 2
Mehrotra, S., Bhattacharjya, S., & Shetty, R. S. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084743 · Cited by 2
Olorunfemi, O., Ayodele, O. H., & Osunde, R. N. (2025) · D Y Patil Journal of Health Sciences · doi:10.4103/dypj.dypj_49_24 · Cited by 2
Yue, S., Su, M., Zhang, Z., Hao, Z., Li, M., Zhang, L., Zhang, N., Li, Z., Wu, Q., Huang, H., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70096 · Cited by 2
Whitmore, C., Forsythe, J., Benzaquen, A., Domjancic, M., Melamed, O. C., Selby, P. L., & Sherifali, D. (2025) · Primary Health Care Research & Development · doi:10.1017/s1463423625100236 · Cited by 2
Li, Z., Hou, Y., Wang, D., Ma, Y., Guo, Y., & Xu, Y. (2025) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.25-0335 · Cited by 2
Mihevc, M., Miroševič, Š., Lukančič, M. M., Potočnik, T. V., Zavrnik, Č., Šter, M. P., Klemenc–Ketiš, Z., & Susič, A. P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300797 · Cited by 2
Lee, S.-Y., Hayes, L., Ozaydin, B., Howard, S. W., Garretson, A., Bradley, H., Land, A. M., Pritchett, A., Furr, A. L., Allgood, A. M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2927585/v1 · Cited by 2
Engineered tools to study endocrine dysfunction of pancreas
Alver, C. G., Domínguez‐Bendala, J., & Agarwal, A. (2024) · Biophysics Reviews · doi:10.1063/5.0220396 · Cited by 1
Ashoka, H., Pradeep, S., Nair, K., & Kareenhalli, V. V. (2024) · Mathematics in Medical and Life Sciences · doi:10.1080/29937574.2024.2431821 · Cited by 1
Precision Medicine in Diabetes Management: From Theory to Clinical Practice
Pooja, K., Bharathi, D. R., Ahmed, S. S., Jayanth, B. M., & Chandan, K. (2025) · International Journal of Pharmaceutical Investigation · doi:10.5530/ijpi.20250047 · Cited by 1
Zhang, B., Powwattana, A., Sillabutra, J., Liu, G., Li, S., & Kalampakorn, S. (2025) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106251319541 · Cited by 1
Shaheer, A., Jallo, M. K. I., & Akhtar, S. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3192 · Cited by 1
Dewvi, P. A. S., Aryaweda, M. D. W., Mahayana, N. P. K., Devi, N. P., Yadmika, N. P. W. P., & Sumartini, N. K. (2025) · Intisari Sains Medis · doi:10.15562/ism.v16i2.2413 · Cited by 1
Zhao, W., Niu, X., Zhou, X., Shi, R., & Zhou, X. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33885-4.00007-x · Cited by 1
Islam, T., & Uddin, M. N. (2025) · EMJ Diabetes · doi:10.33590/emjdiabet/rkyo7834 · Cited by 1
Vitamin D level and glycemic control in type 2 diabetes mellitus
Alhussary, D. N., & Mohialdeen, S. K. (2025) · Regulatory Mechanisms in Biosystems · doi:10.15421/0225094 · Cited by 1
Aslam, B., Hussain, A., Sindhu, Z. U. D., Mushtaq, A., Kousar, S., Sajid, M. R., Khan, R. U., Ahmad, S., Perillo, A., & Alhidary, I. A. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2609383 · Cited by 1
Modeling the spectrum of type 2 diabetes in mice
Grieco-St-Pierre, L., Hoyeck, M. P., Estall, J. L., & Bruin, J. E. (2026) · Endocrinology · doi:10.1210/endocr/bqag005 · Cited by 1
Kirubakaran, D., Palani, B., Vajjiravelu, R., Jayakodi, S., & Poongavanam, S. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100706 · Cited by 1
Anton, I. C., Mititelu-Tarțău, L., Popa, T., Poroch, M., Poroch, V., Reurean‐Pintilei, D., & Botnariu, G. E. (2022) · Healthcare · doi:10.3390/healthcare10071153 · Cited by 1
A series of patients with hospital-acquired diabetic ketoacidosis (HADKA): a descriptive analysis
Williams, D. M., Taverner, S., Watson, R. E., George, S., Edwards, A., Shaikh, A. H., & Udiawar, M. (2022) · Clinical Medicine · doi:10.7861/clinmed.2022-0300 · Cited by 1
Self-citation
Metadata
- Authors
- Williams, D. M., Jones, H., & Stephens, J. W.
- Affiliations
- Swansea Bay University Health Board (GB)
- Corresponding author
- Williams, David M
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2022-02
- Volume
- Volume 15
- Pages
- 281-295
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC8824792
- OpenAlex
- W4210447482
- Cited by
- 121
- References
- 107
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 31 · 2023: 21 · 2022: 9
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, personalized medicine, glycemic control, diabetes pharmacotherapy, diabetes phenotypes, genetic biomarkers, comorbidities, hypoglycemia, medication adherence, patient satisfaction, quality of life, diabetes distress, weight management, treatment goals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.